Inactive Ingredient Search for Approved Drug Products

Latest News: FDA announced upcoming changes to the Inactive Ingredient Database: more information


Search Names Beginning with Z

Inactive Ingredient Route Dosage Form CAS Number UNII Maximum Potency per unit dose Record Updated
ZEIN ORAL TABLET 9010666 80N308T1NN 5mg
ZEIN ORAL TABLET, COATED 9010666 80N308T1NN 25mg
ZEIN ORAL TABLET, DELAYED RELEASE 9010666 80N308T1NN 1.87mg
ZEIN ORAL TABLET, EXTENDED RELEASE 9010666 80N308T1NN 145mg
ZEIN ORAL TABLET, FILM COATED 9010666 80N308T1NN 5.75mg
ZINC INTRAVENOUS INJECTION, SOLUTION 7440666 J41CSQ7QDS NA
ZINC ORAL POWDER 7440666 J41CSQ7QDS NA
ZINC SUBCUTANEOUS INJECTION 7440666 J41CSQ7QDS 0.02%w/v
ZINC SUBCUTANEOUS INJECTION, SOLUTION 7440666 J41CSQ7QDS 0.01%w/v
ZINC SUBCUTANEOUS INJECTION, SUSPENSION 7440666 J41CSQ7QDS 1.09%w/v
ZINC ACETATE SUBCUTANEOUS INJECTION 5970456 FM5526K07A NA
ZINC ACETATE TOPICAL SWAB 5970456 FM5526K07A NA
ZINC CHLORIDE INTRADERMAL INJECTION 7646857 86Q357L16B 7mg
ZINC CHLORIDE OPHTHALMIC SOLUTION 7646857 86Q357L16B NA
ZINC CHLORIDE OPHTHALMIC SOLUTION/ DROPS 7646857 86Q357L16B NA
ZINC CHLORIDE ORAL TABLET 7646857 86Q357L16B 7mg
ZINC CHLORIDE SUBCUTANEOUS INJECTION 7646857 86Q357L16B 0.02%w/v
ZINC CHLORIDE SUBCUTANEOUS INJECTION, SOLUTION 7646857 86Q357L16B 0.02%w/v
ZINC OXIDE INTRAVENOUS INJECTION, SOLUTION 1314132 SOI2LOH54Z NA
ZINC OXIDE RECTAL SUPPOSITORY 1314132 SOI2LOH54Z 375mg
ZINC OXIDE RESPIRATORY (INHALATION) INJECTION, SOLUTION 1314132 SOI2LOH54Z 3.11%w/v
ZINC OXIDE SUBCUTANEOUS INJECTION 1314132 SOI2LOH54Z 0.02%w/v
ZINC OXIDE SUBCUTANEOUS INJECTION, SOLUTION 1314132 SOI2LOH54Z NA
ZINC OXIDE SUBCUTANEOUS INJECTION, SUSPENSION 1314132 SOI2LOH54Z NA
ZINC OXIDE SUBCUTANEOUS SUSPENSION 1314132 SOI2LOH54Z 0.03%w/v
ZINC OXIDE TOPICAL LOTION 1314132 SOI2LOH54Z 16%w/w
ZINC STEARATE BUCCAL TABLET 557051 H92E6QA4FV 2.5mg
ZINC STEARATE ORAL CAPSULE 557051 H92E6QA4FV 2.04mg
ZINC STEARATE ORAL SYRUP 557051 H92E6QA4FV NA
ZINC STEARATE ORAL TABLET 557051 H92E6QA4FV 10mg
ZINC STEARATE ORAL TABLET, COATED 557051 H92E6QA4FV 1.82mg
ZINC STEARATE ORAL TABLET, EXTENDED RELEASE 557051 H92E6QA4FV 36mg
ZINC STEARATE ORAL TABLET, FILM COATED 557051 H92E6QA4FV 15.2mg
ZINC STEARATE SUBLINGUAL TABLET 557051 H92E6QA4FV 2.5mg
ZINC STEARATE TOPICAL CREAM 557051 H92E6QA4FV 6%w/w
ZINC STEARATE TOPICAL OINTMENT 557051 H92E6QA4FV NA
ZINC STEARATE TOPICAL POWDER 557051 H92E6QA4FV 0.1mg/mg
ZINC STEARATE TOPICAL SHAMPOO 557051 H92E6QA4FV 2%w/w
ZINC SULFATE VAGINAL DOUCHE 89DS0H96TB 5%w/w

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 5, 2019
Database Last Updated: July 24, 2019

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English